Market Research Logo

Global Medical Imaging Analysis Software Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global Medical Imaging Analysis Software Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global Medical Imaging Analysis Software Market is anticipated to reach US $3,335.3 million with an attractive CAGR of 8.2% during 2016 – 2022. The major drivers which are enhancing the global medical imaging analysis software market are due to rising due to rapid increase in demand for technically progression market for imaging devices, a lot of investment in medical imaging technologies, increasing geriatric population, due to increasing huge number of enduring research activities and growth in the number of new and advanced products being launched in developing Asian countries. Apart from this, some of the factors which are hampering the market are absence of technical and skilled professionals and due to increasing hacking concerns.

The medical imaging analysis software market is segmented on the basis of software, image, modality, application and end-user. According to software segment, the market is further segmented such as integrated software and standalone software. On the basis of image segment, the market is further subdivided into 2D imaging, 3D imaging, and 4D imaging. On the basis of modality segment, the market is further divided into tomography (Computed Tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET) and single-photon emission tomography (SPECT)), ultrasound imaging, radiographic imaging, and combined modalities. On the basis, of application segment, the market is further subdivided into orthopedic application, dental applications, neurology, cardiology application, oncology applications, oncology applications, mammography applications and urology and nephrology applications. On the basis of end-user segment, the market is further subdivided into hospitals, diagnostic centers, and research centers.

On the basis of geography, the global medical imaging analysis software market is segmented into four major regions such as North America, APAC, Europe and ROW. Currently, North America is accounted to be the largest market share nearly 35% for medical image analysis software due to huge demand for post-diagnostic treatment and better detection. Asia Pacific is a forthcoming market because of rise in per capita income and technological advancements in diagnostic technology. Asia Pacific is projected to be growing upward at the fastest CAGR of over 9.5% during the prediction period due to the increasing saturation of the medical imaging systems in fast developing economies of the Asia Pacific region, such as India and China. Along with this, there are many of the further driving factors that are promoting overall growth of the market such as high R&D intensity by the major market players, investments in the healthcare industry.

There are many key manufacturing companies which are engaged in Esaote S.p.A (Italy), Agfa healthcare (Belgium), Carestream Health, Inc. (U.S.), Aquilab (France), GE Healthcare (U.K.), MIM Software Inc. (U.S.), Philips Healthcare (Netherlands), Merge Healthcare, Inc. (U.S.), Siemens Healthcare (Germany), and Toshiba Medical Systems Corporation (Japan). One of the top most manufacturing company ‘Philips Healthcare” has launched a new advanced diagnostic equipment which has been developed and designed at its one of the two R&D centers which one of them in India (Pune). One of the two products exposed, which are the mobile diagnost opta, one of them, digital X-Ray system is for limited spaces like rigorous care units and operations theatres. Other than that, BV Vectra is a mobile C-arm system devoted to orthopaedic surgical procedures.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. MARKET SCOPE
2. MARKET OVERVIEW
2.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET: EVOLUTION & TRANSITION
2.2. INDUSTRY STRUCTURE
2.3. MANUFACTURING PROCESS
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7.6. GAP ANALYSIS
2.8. COMPETITIVE ANALYSIS
2.8.1. MARKET SHARE ANALYSIS
2.8.2. TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS & MARKET IMPACT
3.1.1. TECHNOLOGICAL DEVELOPMENTS IN MEDICAL IMAGING SYSTEMS AND ANALYSIS SOFTWARE
3.1.2. INCREASING PUBLIC AND PRIVATE SECTOR INVESTMENTS IN THE MEDICAL IMAGING MARKET
3.1.3. RISING APPLICATIONS OF COMPUTER-AIDED DIAGNOSIS (CAD)
3.1.4. GROWING USAGE OF IMAGING EQUIPMENT
3.1.5. GROWING INCIDENCES OF CHRONIC DISEASES
3.1.6. INCREASE IN FLEXIBILITY
3.1.7. RAPID GROWTH IN AGING POPULATION
3.2. MARKET RESTRAINTS
3.2.1. ABSENCE OF SKILLED PROFESSIONALS
3.2.2. INCREASING SOFTWARE HACKING CONCERNS
3.3. MARKET OPPORTUNITIES
3.3.1. CLOUD-BASED IMAGE ANALYSIS SOLUTIONS
3.3.2. EXPANSION IN DEVELOPING MARKETS
3.4. MARKET CHALLENGES
3.4.1. MARKET PENETRATION OF STANDALONE SOFTWARE VENDORS
3.4.2. HIGH COST OF SOFTWARE
4. MARKET SEGMENTATION
4.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY SOFTWARE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION BY SOFTWARE 2014-2023 ($ MILLION)
4.1.5.1. INTEGRATED SOFTWARE
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. APPLICATION
4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.1.5.1.6. KEY CONCLUSIONS
4.1.5.2. STANDALONE SOFTWARE
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. APPLICATION
4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.1.5.2.6. KEY CONCLUSIONS
4.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY IMAGE
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION BY IMAGE 2014-2023 ($ MILLION)
4.2.5.1. 2D IMAGING
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. APPLICATION
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.2.5.1.6. KEY CONCLUSIONS
4.2.5.2. 3D IMAGING
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. APPLICATION
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.2.5.2.6. KEY CONCLUSIONS
4.2.5.3. 4D IMAGING
4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.3. APPLICATION
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.2.5.3.6. KEY CONCLUSIONS
4.3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MODALITY
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION BY MODALITY 2014-2023 ($ MILLION)
4.3.5.1. TOMOGRAPHY
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.3. APPLICATION
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.3.5.1.6. KEY CONCLUSIONS
4.3.5.2. ULTRASOUND IMAGING
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.3. APPLICATION
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.3.5.2.6. KEY CONCLUSIONS
4.3.5.3. RADIOGRAPHIC IMAGING
4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.3. APPLICATION
4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.3.5.3.6. KEY CONCLUSIONS
4.3.5.4. COMBINED MODALITIES
4.3.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.3. APPLICATION
4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.4.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.3.5.4.6. KEY CONCLUSIONS
4.4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY END USER
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION BY END-USER 2014-2023 ($ MILLION)
4.4.5.1. HOSPITALS
4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.3. APPLICATION
4.4.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.4.5.1.6. KEY CONCLUSIONS
4.4.5.2. DIAGNOSTIC CENTERS
4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.3. APPLICATION
4.4.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.4.5.2.6. KEY CONCLUSIONS
4.4.5.3. RESEARCH CENTERS
4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.3.3. APPLICATION
4.4.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.4.5.3.6. KEY CONCLUSIONS
4.5. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY APPLICATION
4.5.1. MARKET DEFINITION AND SCOPE
4.5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.5.4. OPPORTUNITY MATRIX
4.5.5. MARKET SEGMENTATION BY APPLICATION 2014-2023 ($ MILLION)
4.5.5.1. ORTHOPEDIC APPLICATIONS
4.5.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.1.3. APPLICATION
4.5.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.5.5.1.6. KEY CONCLUSIONS
4.5.5.2. DENTAL APPLICATIONS
4.5.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.2.3. APPLICATION
4.5.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.5.5.2.6. KEY CONCLUSIONS
4.5.5.3. NEUROLOGY
4.5.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.3.3. APPLICATION
4.5.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.5.5.3.6. KEY CONCLUSIONS
4.5.5.4. CARDIOLOGY APPLICATIONS
4.5.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.4.3. APPLICATION
4.5.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.4.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.5.5.4.6. KEY CONCLUSIONS
4.5.5.5. ONCOLOGY APPLICATIONS
4.5.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.5.3. APPLICATION
4.5.5.5.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.5.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.5.5.5.6. KEY CONCLUSIONS
4.5.5.6. OBSTETRICS AND GYNECOLOGY APPLICATIONS
4.5.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.6.3. APPLICATION
4.5.5.6.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.6.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.5.5.6.6. KEY CONCLUSIONS
4.5.5.7. MAMMOGRAPHY APPLICATIONS
4.5.5.7.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.7.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.7.3. APPLICATION
4.5.5.7.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.7.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.5.5.7.6. KEY CONCLUSIONS
4.5.5.8. UROLOGY AND NEPHROLOGY APPLICATIONS
4.5.5.8.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.8.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.8.3. APPLICATION
4.5.5.8.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.8.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.5.5.8.6. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF M&A
5.1.2. LIST OF JV
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
5.2. TOP 10 COMPANY ANALYSIS
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRIAL APPLICATION ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. RUSSIA
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. . AGFA-GEVAERT GROUP
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION/FOCUS SECTOR
7.1.4. STRATEGIC INITIATIVES
7.1.5. SCOT ANALYSIS
7.2. AQUILAB
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION/FOCUS SECTOR
7.2.4. STRATEGIC INITIATIVES
7.2.5. SCOT ANALYSIS
7.3. BARCO
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION/FOCUS SECTOR
7.3.4. STRATEGIC INITIATIVES
7.3.5. SCOT ANALYSIS
7.4. BRUKER
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION/FOCUS SECTOR
7.4.4. STRATEGIC INITIATIVES
7.4.5. SCOT ANALYSIS
7.5. CARESTREAM HEALTH, INC.
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION/FOCUS SECTOR
7.5.4. STRATEGIC INITIATIVES
7.5.5. SCOT ANALYSIS
7.6. ELEKTA
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION/FOCUS SECTOR
7.6.4. STRATEGIC INITIATIVES
7.6.5. SCOT ANALYSIS
7.7. ESAOTE S.P.A
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION/FOCUS SECTOR
7.7.4. STRATEGIC INITIATIVES
7.7.5. SCOT ANALYSIS
7.8. GENERAL ELECTRIC COMPANY (GE)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION/FOCUS SECTOR
7.8.4. STRATEGIC INITIATIVES
7.8.5. SCOT ANALYSIS
7.9. INFIMED
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION/FOCUS SECTOR
7.9.4. STRATEGIC INITIATIVES
7.9.5. SCOT ANALYSIS
7.10. MERGE HEALTHCARE INC.
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION/FOCUS SECTOR
7.10.4. STRATEGIC INITIATIVES
7.10.5. SCOT ANALYSIS
7.11. MIM SOFTWARE, INC.
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION/FOCUS SECTOR
7.11.4. STRATEGIC INITIATIVES
7.11.5. SCOT ANALYSIS
7.12. PHILIPS HEALTHCARE
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION/FOCUS SECTOR
7.12.4. STRATEGIC INITIATIVES
7.12.5. SCOT ANALYSIS
7.13. SIEMENS HEALTHCARE
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION/FOCUS SECTOR
7.13.4. STRATEGIC INITIATIVES
7.13.5. SCOT ANALYSIS
7.14. TOSHIBA MEDICAL SYSTEMS CORPORATION
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION/FOCUS SECTOR
7.14.4. STRATEGIC INITIATIVES
7.14.5. SCOT ANALYSIS
7.15. XINAPSE SYSTEMS LTD.
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION/FOCUS SECTOR
7.15.4. STRATEGIC INITIATIVES
7.15.5. SCOT ANALYSIS
LIST OF TABLES
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY SOFTWARE ($ MILLION)
GLOBAL INTEGRATED SOFTWARE BY GEOGRAPHY ($ MILLION)
GLOBAL STANDALONE SOFTWARE BY GEOGRAPHY ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY IMAGE ($ MILLION)
GLOBAL IMAGING BY GEOGRAPHY ($ MILLION)
GLOBAL IMAGING BY GEOGRAPHY ($ MILLION)
GLOBAL IMAGING BY GEOGRAPHY ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MODALITY ($ MILLION)
GLOBAL TOMOGRAPHY BY GEOGRAPHY ($ MILLION)
GLOBAL ULTRASOUND IMAGING BY GEOGRAPHY ($ MILLION)
GLOBAL RADIOGRAPHIC IMAGING BY GEOGRAPHY ($ MILLION)
GLOBAL COMBINED MODALITIES BY GEOGRAPHY ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY END-USER ($ MILLION)
GLOBAL HOSPITALS BY GEOGRAPHY ($ MILLION)
GLOBAL DIAGONAL CENTERS BY GEOGRAPHY ($ MILLION)
GLOBAL RESEARCH CENTERS BY GEOGRAPHY $ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY APPLICATION ($ MILLION)
GLOBAL ORTHOPEDIC APPLICATION BY GEOGRAPHY ($ MILLION)
GLOBAL DENTAL APPLICATION BY GEOGRAPHY ($ MILLION)
GLOBAL NEUROLOGY BY GEOGRAPHY ($ MILLION)
GLOBAL CARDIOLOGY APPLICATION BY GEOGRAPHY ($ MILLION)
GLOBAL ONCOLOGY APPLICATION BY GEOGRAPHY ($ MILLION)
GLOBAL OBSTETRICS AND GYNECOLOGY APPLICATIONS BY GEOGRAPHY ($ MILLION)
GLOBAL MAMMOGRAPHY APPLICATIONS BY GEOGRAPHY ($ MILLION)
GLOBAL UROLOGY AND NEPHROLOGY APPLICATIONS BY GEOGRAPHY ($ MILLION)
NORTH AMERICA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
EUROPE MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
ASIA PACIFIC MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
REST OF THE WORLD MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
LIST OF FIGURES
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY UROLOGY AND NEPHROLOGY APPLICATIONS ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MAMMOGRAPHY APPLICATIONS ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY OBSTETRICS AND GYNECOLOGY APPLICATIONS ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ONCOLOGY APPLICATION ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY CARDIOLOGY APPLICATION ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY NEUROLOGY ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY DENTAL APPLICATIONS ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ORTHOPEDIC APPLICATION ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY HOSPITALS ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY DIAGONALS CENTERS ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY RESEARCH CENTERS ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY TOMOGRAPHY ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ULTRASOUND IMAGING ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY RADIOGRAPHIC IMAGING ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY COMBINED MODALITIES ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY INTEGRATED SOFTWARE ($ MILLION)
GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY STANDALONE SOFTWARE ($ MILLION)
UNITED STATES (U.S.) MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
CANADA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
UNITED KINGDOM (UK) MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
FRANCE MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
GERMANY MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
SPAIN MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
ITALY MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
ROE MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
INDIA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
CHINA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
JAPAN MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
KOREA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
AUSTRALIA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
ROAPAC MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
LATIN AMERICA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)
MENA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report